Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Launched by ABIOMED INC. · Sep 3, 2009
Trial Information
Current as of May 27, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed Consent
- • Subject presenting with STEMI undergoing primary PCI
- * Patient presents with at least 1 of the following:
- • Unstable blood pressure
- • Tachycardia and tissue hypoperfusion
- • The need for intravenous pressor or inotropic support
- * Patient presents with STEMI:
- • CK-MB\>2x normal
- Exclusion Criteria:
- • Unwitnessed cardiac arrest
- • Abnormalities of the aorta
- • Recent stroke or TIA
- • Mural thrombus in the left ventricle
About Abiomed Inc.
Abiomed Inc. is a leading medical technology company specializing in heart pump and circulatory support devices. With a commitment to advancing patient care, Abiomed develops innovative therapies designed to treat coronary artery disease and heart failure, significantly improving patient outcomes. The company is renowned for its cutting-edge Impella heart pumps, which provide temporary mechanical support for patients undergoing high-risk procedures or experiencing severe cardiovascular events. Through rigorous clinical trials and a dedication to research and development, Abiomed aims to transform the landscape of cardiovascular treatment and enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Houston, Texas, United States
Columbus, Ohio, United States
Hartford, Connecticut, United States
Chicago, Illinois, United States
Murray, Utah, United States
York, Pennsylvania, United States
Columbus, Ohio, United States
Wormleysburg, Pennsylvania, United States
Shawnee Mission, Kansas, United States
Hawthorne, New Jersey, United States
Patients applied
Trial Officials
William O'Neill, M.D.
Principal Investigator
Not affiliated with Abiomed
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials